| X23-10-ZQ416 |
JAK inhibitor SAR-20347, Purity ≥98%
|
|
| X23-10-ZQ418 |
JAK inhibitor SD 1008, Purity ≥98%
|
|
| X23-10-ZQ419 |
JAK inhibitor Solcitinib, Purity ≥98%
|
|
| X23-10-ZQ420 |
JAK inhibitor TCS 21311, Purity ≥98%
|
|
| X23-10-ZQ423 |
JAK inhibitor TG-89, Purity ≥98%
|
|
| X23-10-ZQ424 |
JAK inhibitor Tofacitinib, Purity ≥98%
|
|
| X23-10-ZQ425 |
JAK inhibitor Tyk2-IN-3, Purity ≥98%
|
|
| X23-10-ZQ426 |
JAK inhibitor Tyk2-IN-7, Purity ≥98%
|
|
| X23-10-ZQ427 |
JAK inhibitor Tyk2-IN-8, Purity ≥98%
|
|
| X23-10-ZQ428 |
JAK inhibitor Upadacitinib, Purity ≥98%
|
|
| X23-10-ZQ430 |
JAK inhibitor WHI-P258, Purity ≥98%
|
|
| X23-10-ZQ431 |
JAK inhibitor WHI-P97, Purity ≥98%
|
|
| X23-10-ZQ432 |
JAK inhibitor WP1066, Purity ≥98%
|
|
| X23-10-ZQ433 |
JAK inhibitor XL019, Purity ≥98%
|
|
| X23-10-ZQ434 |
JAK inhibitor ZM 39923 HCl, Purity ≥98%
|
|
| X23-10-ZQ435 |
JAK inhibitor ZM 449829, Purity ≥98%
|
|
| X23-10-ZQ436 |
JAK inhibitor ZM39923, Purity ≥98%
|
|
| X23-10-ZQ999 |
JAK inhibitor PF-06651600, Purity ≥98%
|
|
